Satellos Bioscience (TSX:MSCL) EV-to-EBITDA : -0.41 (As of May. 12, 2024)

Satellos Bioscience EV-to-EBITDA Chart

Satellos Bioscience Quarterly Data
	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial									-0.66	-2.15	-0.51	-0.38	-0.57

Competitive Comparison of Satellos Bioscience's EV-to-EBITDA

For the Biotechnology subindustry, Satellos Bioscience's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Satellos Bioscience's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Satellos Bioscience's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Satellos Bioscience's EV-to-EBITDA falls into.

Satellos Bioscience EV-to-EBITDA Calculation

Satellos Bioscience's EV-to-EBITDA for today is calculated as:

Satellos Bioscience's current Enterprise Value is C$6.36 Mil.
Satellos Bioscience's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-15.71 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Satellos Bioscience  (TSX:MSCL) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Satellos Bioscience's PE Ratio for today is calculated as:

Satellos Bioscience's share price for today is C$0.47.
Satellos Bioscience's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.180.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Satellos Bioscience EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Satellos Bioscience's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Satellos Bioscience (TSX:MSCL) Business Description